Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8041-8050 of 11994

Page
per page
  1. Amantadine HCl
    B1486 Amantadine HCl
    Summary: Dopamine receptor agonist
  2. Lornoxicam
    B1441 Lornoxicam
    Target: COX
    Summary: COX-1/COX-2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.59 mg/mL
  3. Amlodipine Besylate
    B1411 Amlodipine Besylate
    Summary: Block of L-type calcium channel
      ≥26.05 mg/mL
  4. HA14-1
    A8168 HA14-1
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and cell-permeable
      insoluble in H2O; ≥20.45 mg/mL
  5. Fluoroorotic Acid, Ultra Pure
    A2531 Fluoroorotic Acid, Ultra Pure
    Summary: 5-Fluoroorotic acid
      insoluble in EtOH; insoluble in H2O; ≥23.1 mg/mL
  6. PSI-6206
    A8189 PSI-6206
     3 Citation
    Target: HCV polymerase
    Summary: Inhibitor of HCV RNA polymerase,potent and selective
      ≥13.1 mg/mL
  7. Cryptotanshinone
    N1843 Cryptotanshinone
    Summary: STAT3/AChE inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.23 mg/mL
  8. vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]
    A1098 vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]
    Summary: vitamin D binding protein precrusor
      ≥125.4 mg/mL
  9. ML347
    B3688 ML347
    Target: BMP and Other Activin Receptors
    Summary: BMP receptor inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.87 mg/mL
  10. TAPI-1
    B4686 TAPI-1
     2 Citation
    Target: MMP
    Summary: TACE/ADAM17 inhibitor
      ≥24.98 mg/mL

Items 8041-8050 of 11994

Page
per page